GeneTether Therapeutics Inc.
CA$0.12CA$0.00 (0.0%)
GeneTether Therapeutics Inc.: Healthcare · Biotechnology.
NEO · AWKN.NE · CAD
Stock price, earnings
Quote as of Dec 6, 2024, 07:55 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Awakn Life Sciences Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Awakn Life Sciences Corp., a biotechnology firm headquartered in Toronto, Canada, specializes in the discovery, development, and provision of psychedelic therapies. Its mission is to address addiction and other mental health challenges throughout the United Kingdom and across Europe.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:22 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2022 | Jun 14, 2022 | -CA$0.11+35.29% vs estimate | CA$253.15K-24.88% vs estimate |
|---|
| Q4 2021 | Apr 28, 2022 | -CA$0.16-6.67% vs estimate | CA$204.30K+48.04% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.12CA$0.00 (0.0%)
GeneTether Therapeutics Inc.: Healthcare · Biotechnology.
$5.93+$0.08 (+1.37%)
Clearmind Medicine Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.78% below the high.
CA$0.01+CA$0.01 (+100.0%)
Luff Enterprises Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.01-CA$0.01 (-33.33%)
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
CA$0.08CA$0.00 (0.0%)
Bloom Health Partners Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.4% below the high.
CA$0.01CA$0.00 (0.0%)
GABY Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
CA$0.04CA$0.00 (0.0%)
Empower Clinics Inc.’s quoted price sits in the lower half of its reported 52-week range, 11.11% below the high.
CA$0.08-CA$0.01 (-11.11%)
Intellipharmaceutics International Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.94% below the high.